Sinus delivery of sustained release therapeutics
First Claim
Patent Images
1. A method for treating a sinus condition comprising:
- accessing a paranasal sinus cavity with a delivery device loaded with a plurality of biodegradable implants;
activating the delivery device to a first configuration to deliver a first of the plurality of biodegradable implants to the paranasal sinus cavity; and
subsequently activating the delivery device to a second configuration to deliver a second of the plurality of biodegradable implants to the paranasal sinus cavity,wherein the first biodegradable implant comprises an active agent.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
248 Citations
17 Claims
-
1. A method for treating a sinus condition comprising:
-
accessing a paranasal sinus cavity with a delivery device loaded with a plurality of biodegradable implants; activating the delivery device to a first configuration to deliver a first of the plurality of biodegradable implants to the paranasal sinus cavity; and subsequently activating the delivery device to a second configuration to deliver a second of the plurality of biodegradable implants to the paranasal sinus cavity, wherein the first biodegradable implant comprises an active agent. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
Specification